NCT02302339 2019-09-06A Study of Glembatumumab Vedotin as Monotherapy or in Combination With Immunotherapies in Patients With Advanced MelanomaCelldex TherapeuticsPhase 2 Terminated132 enrolled 16 charts
NCT02351037 2018-08-14Study of Ibrutinib in Subjects With Acute Myeloid LeukemiaPharmacyclics LLC.Phase 2 Terminated36 enrolled 12 charts